Switzerland’s Roche strikes $3.5bn deal to buy US drugmaker 89bio

Client Challenge
JavaScript is disabled in your browser.
Please enable JavaScript to proceed.
A required part of this site couldn’t load. This may be due to a browser
extension, network issues, or browser settings. Please check your
connection, disable any ad blockers, or try using a different browser. More
